In COVID-19 clinical update #74, Daniel Griffin covers infections in vaccinated individuals, expansion of Regeneron monoclonal antibody cocktail for prophylaxis, neutralization of variants by antibodies produced by infection or vaccination, longer hospital stays associated with remdesivir treatment, and post-acute sequelae of infection and impact on quality of life 1-6 months after illness.
每周播报：https://www.microbe.tv/twiv/
推特：https://twitter.com/DanielGriffinMD
引文：https://www.microbe.tv/twiv/twiv-790/
交流：Send your questions for Dr. Griffin to daniel@microbe.tv
祝平安。
